November 5 - The Impact of Women Running for State Office
Sign-up today for your complimentary subscription to the State Net Capitol Journal to stay up-to-date on the latest news from America’s statehouses.
Editor: Rich Ehisen
Associate Editor: Korey Clark
Editorial Advisor: Lou Cannon
Contributing Editor: Mary Anne Peck
Graphic Design: Vanessa Perez Design
Ideas and suggestions are always welcome. Please let us know how we can improve your newsletter! We welcome your feedback.
State Net Sign-on Page
State Net Product Page
HomeSpotlight Story | Bird’s Eye View | Budget & Taxes | Politics & Leadership | Governors | Hot Issues | Once Around the Statehouse Lightly
Minnesota state Rep. Dave Baker (R) sponsored a bill (HB 1440) this session that would have imposed a “penny a pill” fee on every opioid painkiller pharmaceutical companies sold in the state to provide funding for opioid abuse prevention and treatment.
The measure was personal for Baker, having lost a child to an opioid overdose.
“I’m a pissed off dad,” he said. “My son isn’t here anymore. The state has spent billions and [the drug companies] have profited billions.”
But under heavy lobbying from the pharmaceutical industry, the fee was stripped from Baker’s bill, and the proposal subsequently stalled in the Senate.
Similar efforts have met with the same fate in several other states, including California, Delaware, Iowa, Kentucky, Maine, Massachusetts, Montana, New Jersey, Tennessee and Vermont. Lawmakers in those states said they would try again next year.
Only New York has managed to pass an opioid tax bill (SB 7507) this session. The bill imposes a fee on opioid manufacturers and distributors, based on the amount of the drug they sell in the state, and prohibits them from passing along that fee to consumers or insurers. But the measure has been held up by a lawsuit brought by the Healthcare Distribution Alliance, a national trade group that represents drug distributors.
Back in Minnesota, Baker is planning a shift of focus in 2019, to pharmaceutical licensing. He said bars and liquor stores pay the state thousands of dollars in licensing fees each year, while pharmaceutical companies pay only a few hundred dollars per year in such fees. (GOVERNING, LEXISNEXIS STATE NET)